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In Brief
Zhang et al. uncover a mechanism whereby Drosophila RBF, via E2F1, regulates Hippo signaling by modulating the formation of Yki/Sd complexes, thereby controlling Yki transcriptional outputs and apoptosis, organ size, and gut homeostasis regulation. The RB and E2F interaction is conserved in human cells and may broadly impact tissue homeostasis.
INTRODUCTION
The balance between cell proliferation and apoptosis plays a fundamental role during development and tissue homeostasis. Perturbations in this balance often lead to cancer or degenerative diseases. The Hippo signaling pathway is an evolutionarily conserved kinase cascade that has been established as a key regulator of organ size and tissue homeostasis (Yu et al., 2015; Johnson and Halder, 2014; Pan, 2010) in Drosophila and mice. Core components of this pathway include the Hippo kinase (Hpo or MST1/2 in mammals), which phosphorylates and activates Warts (Wts or LATS1/2 in mammals), which in turn phosphorylates and inactivates the transcriptional coactivator Yorkie (Yki or YAP/TAZ in mammals) by targeting it for nuclear export and degradation (Yu et al., 2015; Johnson and Halder, 2014; Pan, 2010) . Yki/YAP/TAZ trigger the transcription of target genes, the best characterized of which either promote cell proliferation or suppress apoptosis and thereby affect tissue growth (Pan, 2010) . Abnormally elevated YAP/TAZ levels and nuclear enrichment of these proteins have been observed in various human cancers (Yu et al., 2015; Johnson and Halder, 2014) , while hyperactivation of Hpo promotes apoptosis (Pantalacci et al., 2003; Udan et al., 2003) , suggesting that proper control of Hippo signaling is crucial for tissue homeostasis. As transcriptional coactivators that lack a DNA-binding domain, Yki/YAP must interact with the DNA-binding transcription factors, namely Scalloped (Sd or TEAD1-4 in mammals), to effect target gene expression (Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008; Zhao et al., 2008) . Genome-wide chromatin-binding analyses revealed that many of the effects of Yki/YAP/TAZ on transcriptional activity occur via distal enhancers (Stein et al., 2015; Zanconato et al., 2015; Oh et al., 2013) , suggesting that Yki/YAP/TAZ recruit various transcription factors, chromatin modulators, or epigenetic markers to regulate expression of their targets. This idea has been confirmed in recent studies that showed Yki/YAP/TAZ can interact not only with Sd/TEADs family proteins but also with GAGA factors, SWI/SNF complex subunits, Nuclear receptor coactivator 6 (Ncoa6), and the ecdysone receptor coactivator Taiman (Tai) in various tissue contexts Zhu et al., 2015; Qing et al., 2014; Skibinski et al., 2014; Jin et al., 2013; Oh et al., 2013) . It also has been shown that the Tondu-domain-containing growth inhibitor (Tgi) (VGLL4 in mammals) directly competes with Yki for Sd binding, resulting in inhibition of Yki-regulated transcription (Guo et al., 2013 ; Koontz et al., 2013) . In mammals, VGLL4 competes with YAP for TEAD4 binding via a similar mechanism (Zhang et al., 2014) . In the presence of active Hippo signaling, the lack of nuclear Yki/YAP allows Tgi/VGLL4 to complex with Sd/TEADs and promotes transcriptional repression. When Hippo signaling is silenced, Yki/YAP translocate into the nucleus and displace Tgi/VGLL4 from Sd/TEADs, leading to transcriptional activation and tissue growth (Koontz et al., 2013) . These studies yielded a model in which Sd/TEADs could act as a platform for integrating different signal inputs to regulate tissue homeostasis. Since Hippo signaling has been found to cross-talk with multiple pathways in a context-dependent manner (Yu et al., 2015) , we may consider Hippo signaling as a complex network rather than a single linear pathway. However, how Hippo signaling might synergize or compete with other signaling and transcription control systems that affect cell proliferation and survival remains obscure.
The RB-E2F pathway has long been known as a critical regulator of cell-cycle progression. In this system, RB binds to E2F/ Dp complexes and recruits chromatin and histone regulators to E2F-regulated promoters for repression of target genes (Stevaux and Dyson, 2002) , many of which promote cell proliferation. Functional inactivation of RB relieves the repression from E2F/ Dp complexes, which in turn promote cell-cycle progression. RB has been established as a tumor suppressor that normally suppresses cell proliferation. In addition, its activity affects cell differentiation and rates of apoptosis (Chau and Wang, 2003) . Inactivation of Rb in mouse embryo induced aberrant apoptosis that can be inhibited by E2F1 deficiency, demonstrating a function as a suppressor of E2F1-mediated apoptosis (Tsai et al., 1998) . Indeed, ectopic expression of E2F1 leads to apoptosis in Drosophila, cultured cells, and transgenic mice (van den Heuvel and Dyson, 2008) . Consistently, E2F1 knockout mice show higher rates of tumor development and lower rates of thymic apoptosis (Nevins, 2001) . In contrast, RB can also act in a proapoptotic manner by functioning in a transcriptionally active RB/E2F1 complex that promotes expression of pro-apoptotic genes in highly proliferative cells (Dick and Rubin, 2013) . These studies suggest that the ability of RB/E2F1 to regulate tissue homeostasis (growth versus apoptosis) may be dictated by the cellular context, although its precise mechanisms of control are less well defined.
In this study, we found that Drosophila E2F1 and RBF regulate apoptosis via interactions with Hippo signaling, and thereby affect organ size and tissue homeostasis. Analysis of this interaction revealed that E2F1 competes with Yki for binding to Sd, and that this competition affects the expression of the Yki target genes Diap1, expanded (ex), and bantam (ban) . Besides these classical Yki targets, our DamID-seq and RNA-seq data define a set of Yki targets that can be negatively regulated by E2F1. Gene ontology analysis showed that these genes play diverse roles during development and tissue homeostasis, suggesting that E2F1/Yki competition is a broad phenomenon. Furthermore, our data show that RBF levels affect the output of this competition and indicate that the mechanism is conserved in human cells, where YAP, E2F1, and TEAD1 show analogous interactions. In summary, our study uncovers a previously unknown mechanism in which RBF/RB regulates Hippo signaling by modulating the balance of Yki/Sd (or YAP/TEAD1 in human cells) activator and E2F1/Sd (or hE2F1/TEAD1 in human cells) repressor complexes.
RESULTS

Drosophila RBF Positively Regulates Yki Target Genes
To identify new regulators for organ size control, we performed an RNAi screen in which we scored for alterations of Drosophila wing size. In the screen, we found that RNAi-mediated depletion of Rbf using nubGal4 resulted in the formation of abnormally small wings with normal wing vein patterning ( Figures 1A-1B) . Similarly, knockdown of Rbf using enGal4 reduced wing size specifically in the posterior compartment (Figures S1A and S1A 0 ), and Rbf
14
/Rbf 14 homozygous mutant eyes generated by the EGUF/hid method (Stowers and Schwarz, 1999) were significantly reduced in size ( Figures 1C and 1C 0 ). In the developing larval wing, Rbf-depleted cell clones displayed significantly reduced size ( Figure 1D ), as also shown in Datar et al. (2000) . These observations indicate that Rbf is essential for normal cell and tissue growth. Although this is surprising when one considers RBF's function in restraining cell proliferation (Classon and Harlow, 2002) , it is consistent with previous reports from Drosophila (Tanaka-Matakatsu et al., 2009; Datar et al., 2000) that suggest that Rbf mutant cells are sub-viable.
In investigating RBF's growth regulatory function, we tested interactions with Hippo/Yki signaling, a highly conserved pathway that also regulates cell proliferation and organ size. We first investigated whether RBF is required for the expression of Yki target genes. In the wing disc, RNAi depletion of Rbf led to a significant reduction in the expression of Diap1-lacZ ( Figures  1E-1F 0 ), a well-characterized Yki target. Knockdown of Rbf using mirrGal4 in the dorsal part of the eye disc also reduced Diap1-GFP expression ( Figure S1B ). Consistently, overexpression of CycD/Cdk4, whose kinase activity can inactivate RBF (ConnellCrowley et al., 1997) , also suppressed the expression of Diap1-lacZ ( Figure S1C ). Conversely, overexpression of Rbf significantly increased the expression of Diap1-GFP (Figures S1D and S1D 0 ) and another Yki target, ex-lacZ ( Figures  1G-1G 00 ). Thus, RBF regulates the expression of Yki target genes.
E2F1/Dp Negatively Regulates Yki Target Genes
Given that a major function of RBF is to act as a corepressor for the E2F1 and E2F2 transcription factors, we examined whether RBF regulated Hippo signaling in an E2F-dependent manner. We found that the reduction of Diap1-GFP induced by the depletion of Rbf could be reversed by E2f1 knockdown ( Figures  1H-1H 00 ). This suggests that RBF could affect organ size through E2F1 and Yki. Further tests showed that overexpression of E2f1 significantly decreased levels of Diap1-GFP (Figures 2A-2B 0 ). However, overexpression of E2f2, a non-essential paralog of E2f1 that acts as a repressor, showed no effect on Diap1-GFP expression ( Figure S1E ), suggesting a specific role for E2F1. We then investigated the suppressive effect of E2F1 PIP3A , a stabilized but active form of E2F1 (Zielke et al., 2011) , on Yki activity. Overexpressed E2f1 PIP3A strongly reduced the expression of Diap1 as indicated by Diap1-lacZ and Diap1 staining 00 ). Next, we performed a MARCM clone assay to investigate whether E2f1 overexpression might inhibit tissue growth in the wing disc. Cell clones overexpressing E2f1 and Dp grew significantly less than wild-type controls ( Figures 2C-2E 0 ), and the expression of Diap1 in these clones was reduced, suggesting that the transcriptional activity of Yki was suppressed ( Figure 2E ). Consistent with this, clones overexpressing E2f1+Dp showed less ex-lacZ expression (Figures 2F and 2F 0 ) . Overexpression of E2f1 also led to a significant reduction in the expression of ban-lacZ ( Figures 2G and 2G 0 ), another established target of Yki (Nolo et al., 2006; Thompson and Cohen, 2006) . Since E2F1 requires complex formation with Dp to function, we asked whether the E2F1-mediated suppression of Yki targets was Dp-dependent. As expected, knockdown of Dp blocked the inhibitory effect of E2F1 on the expression of Diap1-lacZ ( Figures  2H-2I 0 ). These results demonstrate that E2F1 suppresses Yki activity in a Dp-dependent manner.
Yki-E2F1 Epistasis
We next investigated the epistatic relationships between E2F1 and Hippo pathway components. We found that depletion of hpo using RNAi did not affect the reduction in Diap1-GFP expression caused by E2f1+Dp overexpression (Figures 3A and 3A 0 ). This suggests that the suppression of Yki target gene expression by E2F1 occurs downstream of Hpo. We checked whether the transcription of the Yki dimerization partner, scalloped (sd) might be regulated by E2F1. However, levels of sd-lacZ were not affected by ectopic E2f1+Dp (Figures 3B and   3B 0 ), suggesting that E2F1 does not suppress Yki activity by controlling sd expression. Interestingly, in cells overexpressing E2f1+Dp, protein levels of Yki were reduced ( Figures 3C-3D 0 ), despite a lack of change in levels of yki mRNA ( Figure 3E ). Knockdown of E2f1, however, caused no detectable change in the protein levels of Yki ( Figures 3F and 3F 0 ). This observation suggested that overexpression of yki might rescue the E2f1 overexpression phenotype. Indeed, overexpression of a constitutively active mutant version of Yki, Yki S168A , reversed the loss of ex-lacZ expression caused by high levels of E2f1 ( Figures  3G-3H 0 ). Taken together, these data indicate that E2F1 acts in parallel or upstream of Yki to regulate the expression of Hippo pathway targets (e.g., Diap1 and ex).
We next investigated the effects of loss of E2F1 function on the expression of Yki targets. In E2f1-depleted cells, the expression of either Diap1-GFP ( Figures S2A and S2A 0 ) or ex-lacZ ( Figures  S2C and S2C 0 ) was increased. Similarly, knockdown of Dp also significantly increased the expression of Diap1-GFP ( Figures  S2B and S2B 0 ). Further, the upregulation of ex caused by E2f1-RNAi could be reversed by depletion of yki (Figures S2D and S2D 0 respectively). Overall these results are consistent with the conclusion that E2F1 acts as a repressor of Yki target gene expression.
In the course of these experiments we also discovered that the expression of an E2f1 transcriptional reporter, e2f1-lacZ ( Figure S2I ), E2F1 protein ( Figure S2J ), and the E2F1 target gene PCNA-GFP ( Figures S2K and S2K 0 ) were all upregulated by yki overexpression. These results confirm previous observations suggesting that E2f1 is a downstream target of Hippo signaling (Goulev et al., 2008; Nicolay and Frolov, 2008) . In the context of our other results, this relationship suggests that Yki might negatively regulate its own activity by stimulating E2F1 expression. This kind of regulation, wherein a transcriptional activator indirectly suppresses its own targets, is not infrequent in nature and has been termed ''incoherent'' regulation. (indicated by yellow asterisk in B) of wing discs using hh ts . Anterior compartment labelled by a white asterisk.
(C-E 0 ) UAS-E2f1+Dp-overexpressing clones were generated using the MARCM system. and Yki (Figures 4B and S3B) . Interestingly, overexpression of E2F1 reduced the amount of Yki pulled down by Sd ( Figure 4C ), and conversely, overexpression of Yki diminished the amount of E2F1 pulled down by Sd ( Figure 4D ). Moreover, increasing concentrations of E2F1 decreased the amount of Yki bound to Sd ( Figure S3C ). These results indicate that E2F1 can compete with Yki for Sd interaction. This competition mechanism is similar (H and H 0 ) UAS-GFP-E2f1 and UAS-yki S168A were coexpressed using hh ts . The E2f1-induced ex-lacZ reduction (red asterisk in G) was reversed by yki S168A overexpression (yellow asterisk in H). White asterisk in (H) indicates normal expression of ex-lacZ in the anterior compartment. to that reported for Tgi, which was demonstrated to play a role in Sd-mediated default repression (Guo et al., 2013; Koontz et al., 2013) . Hence, we reasoned that, if E2F1 uses a similar mechanism, knockdown of sd should relieve the suppression of Yki targets by E2F1. Confirming this prediction, knockdown of sd partially reversed the reduction of Diap1-lacZ caused by overexpressed E2f1 (Figures S3D-S3E 0 ). These results suggest that E2F1 competes with Yki for Sd interaction and is required for Sd-mediated default repression of Diap1 in the wing disc. Furthermore, overexpression of Rbf diminished the amount of E2F1 pulled down by Sd ( Figure S4F ), suggesting that RBF reflects the competition of E2F1 and Yki for Sd interaction.
We next tested whether the DNA-binding activity of E2F1 is required for its repression of Yki activity. In previous studies in mammalian cells, the L132 site of human E2F1 was reported to be essential for DNA binding and activation (Cress et al., 1993) . By sequence alignment analysis, amino acid hE2F1 L132 was found to be conserved as E2F1 L259 in Drosophila ( Figure 4E ). The DNA sequence at Drosophila E2F1 codons L259 and G260 was replaced with an EcoRI restriction site sequence (here designated as E2F1
E259
). In addition, E2F1
D296
, which is conserved with hE2F1 D169 , is required for DNA binding and transcriptional activation in Drosophila (Royzman et al., 1999) . A D296 to A296 point mutation of E2F1 (E2F1 D296A ) was generated. In coIP assays, neither E2F1 E259 nor E2F1 D296A were pulled down efficiently with HA-Sd ( Figure 4F ). Furthermore, overexpression of either E2f1 D296A or E2f1 E259 did not suppress Diap1-GFP expression ( Figures 4G-4H 0 , S3H, and S3H 0 ). By chromatin immunoprecipitation (ChIP) assays, we found that overexpression of wild-type E2f1 significantly reduced the Yki binding on the intronic Hippo-responsive element (HRE) of diap1 ( Figure 4M ) and the promoter region of ex ( Figure 4N ). However, E2f1 D296A lost the repression of Yki binding on Diap1
and ex ( Figures 4M and 4N ). These results demonstrate E2F1's DNA-binding domain is required for it to interact with Sd and suppress Yki target genes. Further, we undertook to map the interacting region on E2F1 and Sd. CoIP data showed that both HA-Sd N , which contains the DNA-binding domain of Sd, and HA-Sd C , which lacks the DNA-binding domain, could interact with E2F1 ( Figure S3G ). This surprising result indicates that the DNA-binding domain of Sd is not required for its interaction with E2F1. Moreover, through analyzing published E2F1 and RBF ChIP data from third-instar larvae (Korenjak et al., 2012) , we found a potential binding site of RBF/E2F1, which is close to the intronic HRE of Diap1 ( Figure 4J ). Hence, we tested whether a reporter gene that lacks this RBF/E2F1 binding site but still has Sd binding sites could be regulated by E2F1. Wu et al. (2008) was mutated to a stop codon (Royzman et al., 1999) . We found that E2f1 TDM could interact with HA-Sd by coIP ( Figure S3I ), and that overexpressed E2f1 TDM could suppress Diap1-GFP (Figures 4I and 4I 0 ). By further in vitro binding assay, we found that E2F1 physically binds to Sd, and Yki could diminish this physical interaction ( Figure S3J ). These results indicate that the competition effect and the binding of E2F1 to Sd do not require E2F1's transactivation domain.
To further investigate the potential interactions between Yki and E2F1 on target gene promoters, published E2F1 ChIP-chip data from third-instar larvae (Korenjak et al., 2012) and Yki ChIP-seq data from third-instar wing discs (Oh et al., 2013) were analyzed. The nearest promoter for each binding peak was determined according to FlyBase gene annotation. Compared with randomized peaks distributed in the Drosophila genome, both Yki binding peaks and E2F1 binding peaks were enriched in promoter regions ( Figure S4A ). Focusing on genes targeted by both Yki and E2F1 (i.e., both Yki and E2F1 peaks detected within a ±1 kb region surrounding their transcription start sites), Yki and E2F1 peaks were significantly overlapped according to a Jaccard index calculation ( Figure S4B ). Overall, these data indicate that E2F and Yki/Sd bind adjacent sites in the vicinity of target gene promoters. This genomic colocalization may facilitate the competition between E2F1/Dp and Yki/Sd that affects target gene expression.
E2F1/Sd Interactions Modulate Apoptosis
Since loss of Rbf function reduced wing and eye sizes, RBF may play a role in cell survival during organ development. We found that knockdown of Rbf induced obvious apoptosis in wing discs, as indicated by cleaved caspase-3 staining ( Figures 5A and 5A 0 ). This apoptosis could be suppressed by simultaneous E2f1 knockdown ( Figures 5B and 5B 0 ), suggesting that Rbf loss promotes apoptosis by potentiating E2F1. Consistent with this and a previous report (Neufeld et al., 1998) , overexpression of E2f1+Dp caused significant cell death in wing discs ( Figures 5C and 5C 0 ). Interestingly, this phenotype was significantly diminished by sd (F) To create the E2F1 E259 mutant, the DNA sequence at Drosophila E2F1 codons L259 and G260 (CTGGGA) were replaced with an EcoRI restriction site sequence (GAATTC). E2F1 D296A was generated using the site-directed mutagenesis system. Neither E2F1 E259 nor E2F1 D296A was pulled down by HA-Sd.
(G-I 0 ) Compared with wild-type E2F1 (G and G 0 ), neither E2F1 E259 (H and H 0 ) nor E2F1 D296A (I and I 0 ) showed suppression on the expression of Diap1-GFP.
(J) Schematic representation of the Diap1 loci and a putative binding site of RBF/E2F1. The binding of RBF/E2F1 on Diap1 was analyzed based on published data (Oh et al., 2013; Korenjak et al., 2012 The enrichment of ChIP products on the intronic Hippo-responsive element (HRE) of diap1 and ex promoter were measured by real-time PCR (mean ± SEM, n = 3, t test, *p < 0.05, ***p < 0.001, ns, not significant).
knockdown, suggesting that E2F1 may induce apoptosis by interacting with Sd ( Figures 5D and 5D 0 ). This led us to ask whether E2F1 triggers cell death via its DNA-binding activity. Indeed, the E2F1 E259 DNA-binding mutant had a greatly reduced ability to induce apoptosis (Figures 5E-5E 00 ), indicating that DNA binding of E2F1 is required. Further, overexpression of diap1 successfully restored the reduced clone size caused by E2f1+Dp overexpression ( Figure 5F ), indicating that the reduction in clone size was likely due to increased apoptosis. Taken together, our data are consistent with a model in which RBF/E2F1-regulated apoptosis depends on the balance of pro-apoptotic E2F1/Sd complexes and anti-apoptotic Yki/Sd complexes. (C-D 0 ) Larvae were raised at 18 C and then shifted to 29 C for 36 hr before dissection in third-instar stage. E2f1+Dp overexpression or E2f1+Dp overexpression in conjunction with sd knockdown was driven by nub ts , respectively. Apoptosis was detected by caspase-3 staining.
(E-E 00 ) E2F1 E259 lost the ability to induce apoptosis.
(F) Quantification of clone area of flip-out clones expressing different transgenes as indicated. Values represent mean ± SD (t test, ***p < 0.001, ****p < 0.0001, ns, not significant).
(G-J) Adult females were shifted to 29 C after eclosion for 3 days and midguts were stained with anti-GFP and anti-PH3 antibodies and DAPI. The enterocyte (EC)-specific driver, myo1A-Gal4, tubGal80 ts , UAS-GFP (myo1A ts ,GFP), was used to drive the expression of each of the transgenes shown in (G). ECs were labeled by GFP. Intestinal stem cell (ISC) mitosis was scored and quantified by PH3 + cells. Nuclei in (H, I, and J) were stained by DAPI. Quantification data shown in (G) represents the mean ± SD (t test, **p < 0.01, ****p < 0.0001, ns, not significant).
E2F1/Sd Interactions Modulate Intestinal Stem Cell Proliferation
Given that Hippo signaling plays critical roles in regulating intestinal stem cell (ISC) division during normal midgut homeostasis and regeneration (Karpowicz et al., 2010; Ren et al., 2010; Shaw et al., 2010; Staley and Irvine, 2010; Morris et al., 2006) , we addressed the relevance of E2F1 to Hippo signaling during this process. As widely documented in previous studies (Jiang et al., 2011; Jiang et al., 2009) , the apoptosis of midgut enterocytes (ECs) stimulates cytokine (Upd2, 3) and growth factor (Vn, Spi, Krn) production that non-cell autonomously triggers ICS mitoses and accelerates midgut turnover. Since E2f1 overexpression can induce apoptosis in many cell types, we investigated whether E2F1 non-cell autonomously regulates ISC mitosis by modifying Hippo signaling. Overexpression of E2f1+Dp in ECs, which are post-mitotic, robustly triggered the division of ISCs ( Figure 5G ). In addition, the number of mature GFP + ECs was significantly reduced compared with wild-type control ( Figures 5H and 5I ). These observations are consistent with the induction of EC apoptosis by E2f1+Dp overexpression. Although RNAi-mediated depletion of sd in ECs had no detectable effect on ISC proliferation ( Figure 5G ), depletion of sd in ECs overexpressing E2f1+Dp significantly suppressed the noncell autonomous stimulation of ISC proliferation induced by E2f1+Dp (Figures 5G and 5J) . These results are consistent with those we obtained in wing discs and further support a model in which E2F1/Sd interactions promote apoptosis, whereas Yki/Sd interactions suppress apoptosis, and E2F1 and Yki compete for the interaction with Sd.
Genome-wide Interactions between Yki and E2F1
To investigate whether E2F1/Yki competition is restricted to a few targets, such as Diap1 and ex, or is a broader phenomenon, we used a combination of DamID-seq (Papagiannouli et al., 2014; Choksi et al., 2006; van Steensel et al., 2001 ) and RNAseq to map Yki targets genome-wide in wing discs and assess how these are affected by E2F1. Using DamID-seq, we identified 4,986 binding sites with strong Dam-Yki binding (log2 fold change >3, false discovery rate [FDR] <0.001) when compared with a Dam-only control (Table S1 ). The gene set associated with these binding sites had a very significant overlap (p < 10 À72 , hypergeometric test) with a previous Yki ChIP study also performed on wing discs (Oh et al., 2013) (Figures 6A and  6B ). Using RNA-seq, we identified 281 genes that could be upregulated by yki overexpression and downregulated by depletion of yki using RNAi ( Figure 6C ; Tables S2 and S3 , FDR <0.05). As a way to identify potentially direct transcriptional targets of Yki, the RNA-seq datasets were cross-compared with our Yki DamID data and the Yki ChIP data of Oh et al. Among 281 genes transcriptionally regulated by Yki, 116 had Yki binding sites as assayed by both DamID and ChIP ( Figure 6C and Table S4 ). This set of 116 genes defines likely direct transcriptional targets of Yki. Gene ontology analysis suggested that the abovementioned 116 genes mediate a broad range of functions, including imaginal disc development and growth, regulation of programmed cell death, tissue homeostasis, stem cell fate commitment, etc (Table S5 ).
In order to determine which Yki targets could be modulated by E2F1, we also generated RNA-seq data following overexpression of E2F1. This experiment identified 3,740 genes that were either activated or repressed by overexpressed E2F1 (Tables  S6 and S7 , FDR <0.05). By comparing these 116 direct Yki targets with data from RNA-seq profiling following E2F1 overexpression (Table S7) , we identified 22 genes, including Diap1, that were transcriptionally downregulated by E2f1 overexpression ( Figures 6D and 6E, p = 1.8 3 10 À6 , hypergeometric test). Interestingly, 14 of these 22 genes (red labels, Figure 6E ) have been shown to be differentially regulated during implantation and wound-induced wing disc regeneration (Blanco et al., 2010) . This suggests that E2F1-regulated Yki activity might play a role in damage-induced regeneration. In addition, jaguar (jar), a recently identified Hippo pathway regulator (Kwon et al., 2013) , was found in this 22-gene list, suggesting another mechanism of feedback regulation in Hpo signaling. Altogether, our DamID-seq and RNA-seq analyses confirm that E2F1-Yki interactions affect many target genes and are likely to have diverse biological effects.
Human E2F1 Suppresses YAP Activity by Interacting with TEAD1
We next examined whether the Yki/E2F1 interaction we describe in Drosophila is conserved in mammalian cells. Drosophila E2f1 is an ortholog of human E2f1, E2f2, and E2f3. First, we generated transgenic flies carrying these human genes and tested their roles in regulating the Hippo pathway in Drosophila wing discs. We found that overexpression of either hE2f1 or hE2f2 dramatically reduced Diap1-GFP levels ( Figures 7A-7B  0 ) . Overexpression of hE2f3a and hE2f3b, however, showed no repression of Yki activity ( Figures 7C and 7D ). These data suggest that human E2f1 and E2f2 are functionally conserved orthologs of Drosophila E2f1 with respect to the ability to regulate Yki activity.
Next, we examined the ability of hE2f1 to inhibit the human ortholog of Yki, YAP, in mammalian cells. Overexpression of hE2f1 in MCF7 cells significantly inhibited the expression of CTGF and Cyr61, which are endogenous downstream targets of YAP ( Figure 7E ). Further, ChIP assays showed that overexpression of hE2f1 in HeLa cells significantly reduced the binding of YAP on its characterized targets, CTGF and CDK6 ( Figures 7F  and 7G ). Consistently, coIP assays showed that the hE2F1 protein interacts with the Sd homolog TEAD1 (Figures 7H and  7I ) but not YAP (Figures 7J), and that hE2F1 interferes with YAP binding to TEAD1 in a dose-dependent manner ( Figure 7K ), just as observed for the Drosophila orthologs of these genes. Taken together, these results indicate that the interaction in which E2F1 suppresses Yki/YAP target gene expression by interfering with Yki/YAP binding to Sd/TEAD is functionally conserved between humans and Drosophila ( Figure 7L ).
DISCUSSION
The Hippo and RB-E2F signaling pathways are both highly conserved, and both regulate cell proliferation and survival in diverse scenarios. The overlapping functions of these two pathways suggest that their activities should be coordinated to regulate cell fates. However, few interactions between these pathways have been reported. In this study, we uncover a previously unknown mechanism in which RBF/RB, via E2F1, regulates Hippo signaling by modulating the formation of Yki/Sd (YAP/TEAD1) activator complexes. We show that Drosophila E2F1 counteracts the binding of Yki, a coactivator, to its DNAbinding partner, Sd. Yki/Sd complexes simulate transcription of target genes (Diap1, ex, and ban, etc) that promote cell growth and survival, whereas E2F1 releases Yki:Sd association and suppresses Yki target gene expression, thereby promoting apoptosis and other developmental defects. RBF modified these effects by reducing the activity of the E2F1/Sd repressor complexes, potentially also by a competitive mechanism. This competition mechanism is similar to that reported for Tgi, which was demonstrated to play a role in Sd-mediated default repression (Guo et al., 2013; Koontz et al., 2013) . To determine how specific E2F1's effects on Hippo signaling are, we examined (Oh et al., 2013) to Yki DamID-seq peaks (red) and also the distance distribution of random peaks (by shuffling the ChIP-seq peaks in the genome) to Yki DamID-seq peaks as background (gray). Compared with the random peaks, the ChIP-seq peaks were significantly colocalized with DamID-seq peaks (p < 2.2310 À16 , Kolmogorov-Smirnov test). The MACS software was used to identify the ChIP binding peaks of Yki. The p value cutoff was set to 10
À5
. If more than half the length of one peak region overlapped with an annotated gene, the peak was assigned to that gene. whether E2F1 regulates the activity of four other signaling pathways: Notch (N), Wingless (Wg), Hedgehog (Hh), and Decapentaplegic (Dpp). Like Hpo signaling, each of these pathways is important for wing development. Tests in wing discs using reporter genes for these pathways did not reveal any modifying effects of E2F1 ( Figures S5A-S5D  00 ). These data suggest that E2F1's ability to repress Yki activity is a pathway-specific mechanism, rather than a general transcriptional effect.
The Drosophila genome contains two E2f genes (E2f1 and E2f2). E2F1 (a functionally conserved homolog of mammalian E2F1-3) acts primarily as a transcriptional activator, whereas E2F2 (a functionally conserved homolog of mammalian E2F4-5) represses transcription (Gordon and Du, 2011) . While either RB loss of function or E2F1 gain of function may sensitize cells to apoptosis, the mechanisms underlying these effects are not well understood. In the Drosophila wing, dE2F1-induced apoptosis is sensitive to the levels of the anti-apoptotic factor Diap1 (Morris et al., 2006) . Since Diap1 is by many accounts a downstream target of Hippo signaling, this raises the possibility that RB/E2F1 might regulate apoptosis by controlling this branch of the Hippo pathway. Indeed, our clonal analysis showed that overexpression of Diap1 successfully restored the reduced clone size caused by E2f1 overexpression, strongly indicating that RBF/E2F1-regulated apoptosis depends on the balance of pro-apoptotic E2F1/Sd complexes and anti-apoptotic Yki/Sd complexes. A previous report showed that the induction of apoptosis in Drosophila by RBF depends on E2F2 (Clavier et al., 2014) . However, we observed no suppression of Diap1 expression by E2F2, suggesting a specific role for RB-E2F1 signaling. This is consistent with previous findings showing that E2F-induced apoptosis is associated with some E2F family members (human and Drosophila E2F1) but not with others (Lazzerini Denchi and Helin, 2005; Moon et al., 2005) . Further, our data confirmed previous observations suggesting that E2f1 is a downstream target of Hippo signaling (Goulev et al., 2008; Nicolay and Frolov, 2008) (Table S2 ). This suggests that Yki, via E2F1, might be able to suppress its own activity. Overall the results we present are consistent with a model in which E2F1 acts as a repressor of Yki target gene expression. While a previous study reported that Yki/Sd and E2F1 can activate a set of common targets (e.g., Dachs, PCNA, and Dp) in eye discs (Nicolay et al., 2011) , our analysis did not find that these three genes were activated by both Yki/Sd and E2F1 in wing discs ( Figures  S6A-S6H 0 , Tables S2 and S6 ). These discrepancies are likely due to differences in cell type, which can have large effects on transcriptional outputs.
Our in vivo and in vitro data show that competitive interactions between E2F and Yki/Sd require E2F1's DNA-binding activity. This raises the possibility that E2F1-mediated repression of Yki targets might be mediated through the transcriptional regulation of other unknown repressor(s), which thereby repress Yki activity via an indirect mechanism. To address this, we generated a transactivation domain-defective mutant form of E2f1, E2f1
TDM . This mutant still showed strong inhibition on Diap1 expression, suggesting that the inhibition of Yki targets by E2F1 cannot be attributed to effects via E2F1's transcriptional target(s). To further test this, we performed in vitro binding assays. These experiments showed that purified E2F1 and Sd physically interact quite strongly in vitro. Moreover, this in vitro interaction could be diminished by the presence of Yki ( Figure S3J ). Taken together, these data are consistent with the idea that E2F1 and Yki compete for Sd binding through direct protein-protein interaction. The fact that the E2F DNA-binding domain is required may indicate the involvement of a DNA bridging interaction or may suggest that E2F1 needs to bind to DNA to take on an active conformation that interacts with Sd. Through analyzing published E2F1 ChIPchip data (Korenjak et al., 2012) and Yki ChIP-seq data (Oh et al., 2013) , we found that E2F1 and Yki typically bind in close proximity to each other on common target loci ( Figures  S4A and S4B ). These data suggest that the adjacent binding of E2F1 and Yki/Sd complex on certain regions of the genome may facilitate the negative effect of E2F1 on Yki. However, given our current data, we still cannot rule out the possibility that E2F1 recruits transcriptional repressor(s) to Yki targets, thereby repressing their expression.
To better understand whether the E2F1/Yki interaction we discovered is restricted to a few genes or is a broader phenomenon, we used a combination of RNA-seq and DamID-seq to investigate how Yki targets genome-wide could be affected by E2F1 activity. Our DamID-seq and RNA-seq data define a set of Yki targets that can be negatively regulated by E2F1. Many of these genes have been shown to be differentially regulated during implantation and wound-induced wing disc regeneration, suggesting that E2F1 might play an important role in regulating YAP-controlled regeneration process. Importantly, our data demonstrate that the E2F1/Yki competition is an evolutionarily conserved mechanism. First, overexpression of hE2f1 or hE2f2 in Drosophila wing discs dramatically suppressed expression of the Yki target Diap1. In addition, hE2F1 competed with YAP for binding to the Sd ortholog TEAD1, and effectively suppressed YAP target gene expression in human cells. While it has been previously reported that ectopic expression of hE2f1, hE2f2, and hE2f3 induce apoptosis (Classon and Harlow, 2002) , our experiments suggest that only hE2F1 and hE2F2 retain the ability to repress YAP target genes. Overall, our study describes a previously unappreciated mechanism in which RB/E2F1 activity modifies Hippo signaling by modulating the formation of Yki/Sd activator and E2F1/Sd repressor complexes and thereby influences organ size control and tissue homeostasis.
Since cancerous malignancies are caused by multiple mutations (Loeb et al., 2003) , a major challenge in the study of tumorigenesis is to determine the relative contribution of individual molecular lesions. While Rb is often mutated or inactivated in cancers, the singular loss of Rb function in mice increases apoptosis in some tissues, rather than leading to tumorigenesis (Classon and Harlow, 2002) . Our discovery that E2F1 can suppress YAP activity provides one possible explanation for this conundrum. A previous study showed that low Wnt activity in Rb-deficient cells was due to E2F1-mediated abrogation of b-catenin target gene expression and induction of b-catenin degradation (Morris et al., 2008) . The authors concluded that repression of b-catenin by E2F1 may contribute to E2F1-induced apoptosis. In conjunction with the findings reported here, we suggest that a block to apoptosis may be necessary for Rb mutations to contribute to tumorigenesis and that increased YAP activity may be one way to achieve this. Emerging evidence shows that the Hippo pathway is deregulated in many human cancers (Yu et al., 2015) . However, it remains unknown whether the deregulation of the Hippo pathway contributes to the malignancy of Rb-deficient tumors by suppressing apoptosis. Although elevated levels and nuclear localization of YAP/TAZ occur in various human cancers, mutations in Hippo pathway genes are rare (Yu et al., 2015; Johnson and Halder, 2014) . This indicates that the Hippo pathway may be regulated by many other pathways influencing oncogenesis. However, it is still unknown whether Yki activity is reduced to relatively low levels in cancer cells with defective RB function, or whether other oncogenic pathways bypass Hippo signaling to block RB mutation-induced apoptosis. This will be an interesting avenue for future study.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All fly strains were kept on standard fly medium at 25 C. For temperature shift experiments, larvae were raised at 18 C prior to shifting to the temperature conditions described in the corresponding figure legends and Method Details. Imaginal discs were dissected from 3 rd instar larvae of both sexes. Midguts were dissected from adult females.
METHOD DETAILS
E2f1 Mutagenesis Different E2f1 mutations (E2f1 E259 , E2f1 D296A and E2f1
TDM
) were generated using Site-Directed mutagenesis kit (Thermo Fisher Scientific). Primers used for E2f1 mutagenesis are shown in Table S8 .
Cell Culture
HeLa, HEK293T and MCF7 cell lines were cultured in DMEM supplemented with 10% FBS (Gibco) in 5% CO 2 atmosphere at 37 C. Plasmid transfection was conducted with Lipofectamine (Thermo Fisher Scientific). Drosophila S2 cells were maintained at 25 C in Schneider's medium (Gibco) supplemented with 10% FBS (Gibco).
Immunostaining
After dissection, samples were fixed in PBS with 4% paraformaldehyde (20 min for wing discs or 30 min for midguts), washed in PBS with 0.1% Triton X-100, and blocked in PBS with 0.1% Triton X-100 and 10% NGS for at least 30 min at room temperature. All samples were then stained with primary antibodies at 4 C overnight with the following dilutions: mouse a-b-gal (Promega, 1:500), rat a-Ci (DHSB, 1:20), guinea pig a-E2F1 (X. Bi, 1:200), mouse a-En (DHSB, 1:20), mouse a-Diap1 (B. Hay, 1:200), rabbit a-Yki (L. Zhang, 1:50), rabbit a-hE2F1 (CST, 1:100), rabbit a-hE2F2 (Santa Cruz Biotechnology, 1:100), rabbit a-Cleaved Caspase-3 (CST, 1:100), chicken a-GFP (Thermo Fisher Scientific, 1:1000), rabbit a-PH3 (Millipore, 1:1000), mouse a-Wg (DHSB, 1:5), guinea pig a-Sens (Zhang et al., 2011) , mouse a-Dll (X. Lin, 1:200), mouse a-Ptc (DHSB, 1:50), mouse a-Smo (DHSB, 1:100), rabbit a-Sal (Zhang et al., 2011) , rat a-Dachs (D. Strutt, 1:500) and mouse a-Dp (N. Dyson, 1:5). DAPI (Thermo Fisher Scientific, 1:1000) was used to label nuclei. Staining was detected by Alexa Fluor 488, 568, or 633 conjugated species appropriate secondary antibodies (Thermo Fisher Scientific, 1:1000).
Co-immunoprecipitation and Western Blot
For co-immunoprecipitation, cell lysates were prepared in the lysis buffer (50mM Tris-HCl, pH7.5; 150mM NaCl, 1mM EDTA, 1mM EGTA, 5mM Na 4 P 2 O 7 , 25mM NaF, 1% Triton X-100) with protease inhibitors (cocktail) on ice for 30min. After clarification by centrifugation, the lysates were incubated for 2-6h at 4 C with antibodies pre-bound to protein A/G agarose beads. Beads were washed four times with washing buffer (50mM Tris-HCl, pH7.5; 150mM NaCl, 1mM EDTA, 1mM EGTA, 5mM Na 4 P 2 O 7 , 25mM NaF, 0.5% Triton X-100), and eluted in 1x SDS loading buffer. Eluted samples were analyzed by western blotting. Antibodies used for immunoprecipitation were: mouse a-Myc (MBL International), mouse a-V5 (Thermo Fisher Scientific), mouse a-TEAD1 (BD Biosciences), EZview TM Red Anti-HA Affinity Gel (Sigma-Aldrich) and EZview TM Red Anti-Flag Affinity Gel (Sigma-Aldrich). Primary antibodies used for western blot were: rabbit a-E2F1 (X. Bi, 1:2000), mouse a-Flag (Sigma-Aldrich, 1:10000), rabbit a-Yki (L. Zhang, 1:5000), mouse a-TEAD1 (BD Biosciences, 1:500), mouse a-HA (Santa Cruz Biotechnology, 1:1000), mouse a-V5 (Thermo Fisher Scientific, 1:20000), mouse a-Myc (MBL International, 1:2000), rabbit a-hE2F1 (CST, 1:1000), mouse a-GAPDH (CWBiotech, 1:1000) and mouse a-b-actin (Proteintech Group, 1:5000).
qRT-PCR Quantitative real-time PCR was performed using 23SYBR Green PCR master mix (CWBiotech) in an Agilent Mx3005P qRT-PCR system. The mRNA levels were normalized to rp49 (for wing disc) or GAPDH (for cell line) expression levels. Primers used for qRT-PCR are listed Table S8 .
ChIP Assays Cells were cultured in 15cm dishes (about 90% density), cross-linked with 1% formaldehyde for 15min in room temperature and then sonicated to an average fragment size of $600 bp. Control IgG or specific antibodies, including mouse anti-Myc (MBL), rabbit anti-YAP (Abclonal) were used in each ChIP assay. The immunoprecipitated DNA was quantified using real-time PCR. All values were normalized to the input. Primers for analyzing the ChIP DNA are shown in Table S8 (Qing et al., 2014; Yimlamai et al., 2014; Xie et al., 2013) .
DamID-Seq and Data Analysis
The yki cDNA was cloned into pUASTattB-LT3-NDam (A. Brand) and transgenic flies were generated. Flies carrying the UAS-Dam alone transgene (A. Brand) were used as a control for nonspecific Dam activity. The expression of all transgenes used in DamIDSeq was driven by the nub ts system. Larvae were raised at 18 C, and then shifted to 29 C for 24 hours before dissection of third instar wing discs in ice-cold PBS. Around 100 wing discs were pooled in 200 ml of lysis (TENS) buffer. 2 ml Proteinase K (20 mg/ml, Roche) was added to each sample before homogenization followed by incubation for 7 hours at 65 C. Samples were incubated for 30 min at 37 C with 0.5 mg/ml RNase A (QIAGEN) before phenol/chloroform extraction of genomic DNA (gDNA). Genomic DNA from each genotype ($2.5 mg) was digested with DpnI (NEB) for 16 hr at 37 C in a total volume of 10 ml. 5 ml of DpnI-digested gDNA was ligated to 40 pmol of a double-stranded unphosphorylated adaptor using T4 DNA ligase (NEB) in a total volume of 20 ml. The adaptor was generated by mixing equal volumes of oligo AdRt (100 mM) (5'-CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGA-3') and oligo AdRb (100 mM) (5'-TCCTCGGCCG-3') (Vogel et al., 2007) , at 100 C for 1 min, followed by cooling to RT. To prevent amplification of DNA fragments containing unmethylated GATCs, the adaptor-ligated DNA was cut with DpnII (NEB) for 2 hr at 37 C in a total volume of 80 ml. 20 ml of DpnII-cut DNA was amplified by PCR in a total volume of 80 ml using the primer (5'-GGTCGCGGCCGAG GATC-3') designed to fit to the adaptor (Vogel et al., 2007) . 3-3.5 mg of PCR product was diluted to 45 ml total volume and sonicated to produce 300-400 bp fragments. The sonicated DNA was then digested by Sau3AI at 37 C overnight to remove the adaptors, as Sau3AI can cut the both methylated and non-methylated GATC sites. The Sau3AI-digested product was purified using a QIAquick PCR purification kit (QIAGEN). Purified product was quantified by Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific). The sequencing library was prepared using a TruSeq DNA PCR-Free Sample Preparation kit (Illumina).
DamID-Seq raw reads were mapped to the Drosophila genome (dm6, genome.ucsc.edu) using Bowtie 2 (Langmead and Salzberg, 2012) using default settings. Unmapped reads and reads with a mapping quality score <10 were excluded for downstream analysis. The retained reads were extended 300 base pair toward the 3'-end, and the resulting bam files were subjected to the damidseq_pipe-line analysis (Marshall and Brand, 2015) with parameters -bamfiles -bins=75 -max_norm_value=100 -min_norm_value= -100 -norm_method=kde -qscore1max=1 -qscore1min=0.1 -qscore2max=1. In brief, the method determined the best normalization factor between Dam-fusion and Dam-only samples based on Gaussian kernel density estimation, and determined the optimal number of pseudo-counts added to both samples in order to reduce background noise. The pipeline yielded log2-transformed read count ratios between Dam-fusion and Dam-only experiments in continuous non-overlapping 75-bp windows, which were then used for peak calling. The methods of peak calling and the false discovery rate (FDR) estimation were adapted from the previous publication (Wolfram et al., 2012) . In brief, all 75-bp windows with binding intensity (that is log2 read count ratios) above certain thresholds (here, quantiles from 0.95 to 0.99 with a 0.01 step) were listed and merged. To assess the FDR of these candidate peaks, the intensity values of all windows were randomly shuffled for 100 times, and the mean frequency of difference size of consecutive windows with intensity score above each threshold was calculated. In the shuffled dataset, the relationship between the number of consecutive windows and the frequency of observation such windows was log linear, and could thus be effectively modeled for any number of windows with linear regression. The FDR was calculated as the ratio of expected over observed peaks for different number of consecutive windows above a given intensity threshold. Annotation of significant peaks (FDR<0.01) was based on overlaps between the peaks and genes annotated in the FlyBase or Ensembl databases.
RNA-Seq and Data Analysis
The expression of each transgenes used in RNA-Seq was driven by the nub ts system. Larvae were raised at 18 C, and then shifted to 29 C for 48 hours before dissection. Third instar wing discs of each samples were dissected for RNA-Seq according to standard protocols. Trimmomatic-processed raw RNA-Seq reads were mapped to the FlyBase Drosophila genome version 6.13 using TopHat2 version 2.0.9 (Bolger et al., 2014; Kim et al., 2013) . Mapped reads were counted using HTSeq python package (http:// htseq.readthedocs.io). Differentially expressed genes between experimental and control samples were determined using the MARS method (MA-plot-based method with random sampling model) from the R-package DEGseq, filtering for FDR<0.05 and absolute change bigger than 50 reads as previously described (Jiang et al., 2013) .
Statistical Analysis
Statistical analyses were performed using the Graphpad Prism 7 software package. Statistical significance (P values) of all results were calculated by unpaired two-tailed Student's t-test. Statistical significance was denoted as follows: * P<0.05, ** P<0.01, *** P<0.001 and **** P<0.0001. Figure S1 . Drosophila RBF/E2F1 pathway regulates wing growth and Yki activity, related to (A-B') Knockdown of E2f1 or Dp was driven by enGal4. En staining (B') was used to label the A/P boundary. (C-D') E2f1 knockdown (C-C') or yki/E2f1 double knockdown (D-D') was driven by hhGal4. (E-F') hpo knockdown (E-E') or yki overexpression (F-F') was driven by enGal4, respectively. Ci staining in (E') was used to label the anterior compartment. RNAi-mediated depletion of E2f1 in conjunction with hpo knockdown (G-G') or yki overexpression (H-H') was driven by enGal4, respectively. E2F1 staining in (A'), (F') and (H') The E2F1 ChIP-chip data (Korenjak et al., 2012) and Yki ChIP-seq data (Oh et al., 2013) were processed using custom Rs script (R 3.4.1). The nearest promoter for each peak was determined according to FlyBase gene annotation. Peak regions were piled up in the flanking region of annotated transcription start sites, and then pileup density was calculated and compared to randomized peaks. Target genes of Yki and E2F1 were defined as ones with Yki and E2F1 peaks appearing within +/-1Kb region surrounding their transcription start sites, respectively. In genes targeted by both Yki and E2F1, the extent of peak overlaps was measured by the Jaccard index.
Supplemental Figures and Legends (S1-S6)
The Jaccard index was calculated as the size of intersection peak region over the size of union region. Its value ranges from 0 and 1. Higher Jaccard index values indicate the larger overlaps between peak regions; if two regions are entirely overlapped, the Jaccard index is 1, and if two regions are not overlapped at all, the index is 0. Randomized peaks were generated by randomly re-distributing Yki and E2F1 peaks coordinates across the whole genome, using bedtools (v2. (A-A'') The larvae were raised at 18°C. UAS-E2f1 was overexpressed using hhGal4. Neither wingless-lacZ (wg-lacZ) nor Wg protein levels were decreased in posterior compartment. As wg transcription in wing discs is controlled by Notch signaling, we suggest that E2F1 didn't repress 
